BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35121362)

  • 1. Expression and prognostic analysis of STAT6(YE361) in Hodgkin lymphoma.
    Yang LQ; Wang L; Zuo LK; Ma ZP; Yan SF; Yang MH; Liu B; Li XX
    Pathol Res Pract; 2022 Mar; 231():153781. PubMed ID: 35121362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of STAT6
    Van Slambrouck C; Huh J; Suh C; Song JY; Menon MP; Sohani AR; Duffield AS; Goldberg RC; Dama P; Kiyotani K; Godfrey J; Fitzpatrick C; Kline J; Smith SM; Jaffe ES; Hartmann S; Venkataraman G
    Mod Pathol; 2020 May; 33(5):834-845. PubMed ID: 31822802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT6 and phosphorylated STAT6 are differentially expressed in lymphomas.
    Karpathiou G; Ferrand E; Papoudou-Bai A; Camy F; Honeyman F; Dumollard JM; Peoc'h M
    Pathol Res Pract; 2022 Jan; 229():153697. PubMed ID: 34839096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
    Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W;
    Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
    Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of STAT6 and Phosphorylated STAT6 in Primary Central Nervous System Lymphomas.
    Karpathiou G; Ferrand E; Camy F; Babiuc SM; Papoudou-Bai A; Dumollard JM; Cornillon J; Peoc'h M
    J Neuropathol Exp Neurol; 2021 Sep; 80(9):830-834. PubMed ID: 34388250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
    d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
    Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.
    Elsayed AA; Asano N; Ohshima K; Izutsu K; Kinoshita T; Nakamura S
    Pathol Int; 2014 Jul; 64(7):336-45. PubMed ID: 25047504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and prognostic value of COX- 2, p16(INK4A) and p53 in patients with classical Hodgkin lymphoma].
    Shi Y; Gao Z; Liu C; Huang X; Song Y; Ping L; Zhou L; Zhao M; Huang X; Lai Y; Du T; Li M
    Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):926-32. PubMed ID: 26632465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.
    Myriam BD; Sonia Z; Hanene S; Teheni L; Mounir T
    J Infect Chemother; 2017 Mar; 23(3):121-130. PubMed ID: 28034523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma.
    Koh YW; Han JH; Yoon DH; Suh C; Huh J
    Hematol Oncol; 2018 Feb; 36(1):182-188. PubMed ID: 28744882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of lymphoma subtypes in Shanxi according to latest WHO classification].
    Wang JF; Wang YZ; Chen ZW; Taylor RC
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):218-23. PubMed ID: 16776979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma].
    Wang TT; Li SX; Xia B; Zhao HF; Xu W; Yang HL; Wang XF; Yu Y; Sun BC; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(18):1400-1405. PubMed ID: 28535626
    [No Abstract]   [Full Text] [Related]  

  • 14. Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma.
    Paydas S; Bağır E; Seydaoglu G; Ercolak V; Ergin M
    Ann Hematol; 2015 Sep; 94(9):1545-52. PubMed ID: 26004934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic features and association with Epstein-Barr virus infection in 235 cases of Hodgkin lymphoma from northern China].
    Shi Y; Li X
    Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):84-9. PubMed ID: 25916637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis.
    Wang CG; Ye YJ; Yuan J; Liu FF; Zhang H; Wang S
    World J Gastroenterol; 2010 May; 16(19):2421-7. PubMed ID: 20480530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.
    Kis LL; Gerasimcik N; Salamon D; Persson EK; Nagy N; Klein G; Severinson E; Klein E
    Blood; 2011 Jan; 117(1):165-74. PubMed ID: 20876453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
    Natoli A; Lüpertz R; Merz C; Müller WW; Köhler R; Krammer PH; Li-Weber M
    Int J Cancer; 2013 Oct; 133(8):1945-54. PubMed ID: 23553437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
    Kanakry JA; Li H; Gellert LL; Lemas MV; Hsieh WS; Hong F; Tan KL; Gascoyne RD; Gordon LI; Fisher RI; Bartlett NL; Stiff P; Cheson BD; Advani R; Miller TP; Kahl BS; Horning SJ; Ambinder RF
    Blood; 2013 May; 121(18):3547-53. PubMed ID: 23386127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: correlation with clinical and pathologic findings.
    Gupta GK; Agrawal T; Pilichowska M
    BMC Cancer; 2020 Jun; 20(1):535. PubMed ID: 32513132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.